These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8256499)

  • 1. Recombinant secreted haemagglutinin protects mice against a lethal challenge of influenza virus.
    Vanlandschoot P; Maertens G; Jou WM; Fiers W
    Vaccine; 1993 Sep; 11(12):1185-7. PubMed ID: 8256499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge.
    Galarza JM; Latham T; Cupo A
    Viral Immunol; 2005; 18(1):244-51. PubMed ID: 15802970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic recombinant vaccine expressing influenza haemagglutinin epitope in Salmonella flagellin leads to partial protection in mice.
    McEwen J; Levi R; Horwitz RJ; Arnon R
    Vaccine; 1992; 10(6):405-11. PubMed ID: 1376012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant neuraminidase vaccine protects against lethal influenza.
    Deroo T; Jou WM; Fiers W
    Vaccine; 1996 Apr; 14(6):561-9. PubMed ID: 8782356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homotypic and heterotypic protection against influenza virus infection in mice by recombinant vaccinia virus expressing the haemagglutinin or nucleoprotein of influenza virus.
    Endo A; Itamura S; Iinuma H; Funahashi S; Shida H; Koide F; Nerome K; Oya A
    J Gen Virol; 1991 Mar; 72 ( Pt 3)():699-703. PubMed ID: 2005435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran.
    Ebrahimi SM; Dabaghian M; Tebianian M; Jazi MH
    Virology; 2012 Aug; 430(1):63-72. PubMed ID: 22595444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.
    Robinson HL; Hunt LA; Webster RG
    Vaccine; 1993; 11(9):957-60. PubMed ID: 8212843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against homologous influenza challenge by genetic immunization with SFV-RNA encoding Flu-HA.
    Dalemans W; Delers A; Delmelle C; Denamur F; Meykens R; Thiriart C; Veenstra S; Francotte M; Bruck C; Cohen J
    Ann N Y Acad Sci; 1995 Nov; 772():255-6. PubMed ID: 8546401
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs.
    Chen Z; Matsuo K; Asanuma H; Takahashi H; Iwasaki T; Suzuki Y; Aizawa C; Kurata T; Tamura S
    Vaccine; 1999 Feb; 17(7-8):653-9. PubMed ID: 10067670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge.
    Galarza JM; Latham T; Cupo A
    Viral Immunol; 2005; 18(2):365-72. PubMed ID: 16035948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study of the effectiveness of inactivated chromatographic influenza vaccine prepared from the native and recombinant strains of influenza virus].
    Rozaeva NR; Bichurina MA; Fridman EA
    Vopr Virusol; 1989; 34(6):738-41. PubMed ID: 2633468
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2).
    Tang M; Harp JA; Wesley RD
    Arch Virol; 2002 Nov; 147(11):2125-41. PubMed ID: 12417948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterosubtypic protection against influenza A induced by adenylate cyclase toxoids delivering conserved HA2 subunit of hemagglutinin.
    Staneková Z; Adkins I; Kosová M; Janulíková J; Sebo P; Varečková E
    Antiviral Res; 2013 Jan; 97(1):24-35. PubMed ID: 23036818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice.
    Olsen CW; McGregor MW; Dybdahl-Sissoko N; Schram BR; Nelson KM; Lunn DP; Macklin MD; Swain WF; Hinshaw VS
    Vaccine; 1997 Jul; 15(10):1149-56. PubMed ID: 9269061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An H1-H3 chimeric influenza virosome confers complete protection against lethal challenge with PR8 (H1N1) and X47 (H3N2) viruses in mice.
    Abdoli A; Soleimanjahi H; Tavassoti Kheiri M; Jamali A; Mazaheri V; Abdollahpour Alitappeh M
    Pathog Dis; 2014 Dec; 72(3):197-207. PubMed ID: 25066138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene.
    Bot A; Antohi S; Bot S; Garcia-Sastre A; Bona C
    Int Immunol; 1997 Nov; 9(11):1641-50. PubMed ID: 9418125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunological activity of a deletion mutant of influenza virus haemagglutinin lacking the globular region.
    Sagawa H; Ohshima A; Kato I; Okuno Y; Isegawa Y
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1483-7. PubMed ID: 8757990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors.
    Montgomery DL; Shiver JW; Leander KR; Perry HC; Friedman A; Martinez D; Ulmer JB; Donnelly JJ; Liu MA
    DNA Cell Biol; 1993 Nov; 12(9):777-83. PubMed ID: 8216848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.